Browser does not support script.
"Since 2018, the National Health Service (NHS) spending on branded medicines has been increasing annually by over 5 per cent, excluding expenditure on COVID-19 vaccines and treatments. In the fiscal year 2021-22, the total cost of prescription medicines to the NHS in England, after accounting for confidential discounts and rebates, reached £17.2 billion. A significant portion of this growth can be attributed to increased expenditure on hospital-prescribed medicines. From 2018 to 2022, NHS spending on hospital-prescribed medicines, net of confidential discounts, increased by 35 per cent from £6.7 billion to £9.1 billion."
Print or share
Please refer to the comprehensive report authored by Aris Angelis, James Lomas, Beth Woods, and Huseyin Naci. 23_0275 Report V10